CCA Medical Research

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials
• Psoriasis2 trials
• Hidradenitis suppurativa1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Bristol-Myers Squibb2 trials
• Eli Lilly and Company1 trial
• Incyte Corporation1 trial
• Pfizer1 trial
• Takeda1 trial

Running trials

• Active, not recruiting

  A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

  NCT07244263· Phase 2· Takeda· Source

• Recruiting

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  NCT07116967· Phase 3· Bristol-Myers Squibb· Source

  Contact: David Adam, Site 0073

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriasis1 recruiting

Closed trials

• Withdrawn

  Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1

  NCT05219864· Phase 3· Incyte Corporation· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source

• Completed

  Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

  NCT04036435· Phase 3· Bristol-Myers Squibb· Source

• Completed

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· Phase 3· Pfizer· Source